DYN
DYN
US26818M1080
Dyne Therapeutics, Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
3.11B EUR
3.68B EUR
3B EUR
3.23B EUR
Enterprise Value
2.39B EUR
3.22B EUR
2.41B EUR
2.5B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-4.99x
--
--
--
Price to Sales
--
--
--
--
Price to Book
3.93x
5.24x
3.46x
3.32x
EV/Revenue
--
--
--
--
EV/EBITDA
-4.47x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-10.21%
-13.57%
-15.43%
-9.83%
ende